Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of SPD465 in Adults With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Primary diagnosis of ADHD~* Baseline ADHD-RS-IV score \>= 24~* Non-pregnant females of childbearing potential must comply with contraceptive restrictions~Exclusion Criteria:~* Significantly underweight or morbidly obese~* Comorbid psychiatric diagnosis with significant symptoms such as Axis II disorders or severe Axis I disorders~* History of seizure, tic disorder, or a current diagnosis and/or family history of Tourette's Disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).